CMP001
Search documents
Camp4 Therapeutics (NasdaqGM:CAMP) FY Conference Transcript
2025-12-03 22:02
Camp4 Therapeutics (NasdaqGM:CAMP) FY Conference December 03, 2025 04:00 PM ET Company ParticipantsKelly Gold - CFOJosh Mandel-Brehm - President and CEOConference Call ParticipantsTed Tenthoff - Managing Director and Senior Biotech AnalystTed TenthoffMy name is Ted Tenthoff. I'm a senior biotech analyst at Piper Sandler, and before I begin, I'm required to point out certain disclosures regarding the relationship between Piper and our next presenting company, Camp4, which are presented at the back of the roo ...